Slingshot members are tracking this event:
The first FDA-approved follow-on insulin glargine treatment, BASAGLAR will be available in the U.S. starting on December 15, 2016
Slingshot Insights Explained
Dec 15, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Basaglar, Fda, Approval, Abasaglar, Insulin Glargine Injection, Kwikpen